| Schedule of Related Party Transactions |
| |
|
Six Months Ended
September 30, 2015
(unaudited)
($) |
|
|
Year Ended
March 31, 2015
($) |
|
| Balance due from (to) Pharma and NDM at beginning of period |
|
|
192,505 |
|
|
|
- |
|
| Amounts advanced to Pharma |
|
|
- |
|
|
|
567,633 |
|
| Amounts received from Pharma |
|
|
(164,304 |
) |
|
|
(7,692 |
) |
| Reduction in prepayments to Pharma for clinical trials |
|
|
(247,596 |
) |
|
|
(257,441 |
) |
| Amounts invoiced by Pharma to DDL and TCL |
|
|
- |
|
|
|
(106,193 |
) |
| Expenses paid by Pharma on behalf of DDL and TCL |
|
|
(90,369 |
) |
|
|
134 |
|
| Intellectual Property costs paid by Pharma on behalf of DDL and TCL |
|
|
- |
|
|
|
(946 |
) |
| Foreign exchange differences |
|
|
(947 |
) |
|
|
(2,990 |
) |
| Balance due from (to) Pharma and NDM at end of the period |
|
|
(310,711 |
) |
|
|
192,505 |
|
|